Development of an improved radioiodinated 2-phenylimidazo[1,2-a]pyridine for non-invasive imaging of amyloid plaques

doi:10.1039/C2MD20115A

Paper

Development of an improved radioiodinated 2-phenylimidazo[1,2-a]pyridine for non-invasive imaging of amyloid plaques

Published Jul 1, 2012 · B. Yousefi, A. Manook, B. Reutern

MedChemComm

UNKNOWN SJR score

10

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

A series of novel phenyl-imidazo[1,2-a]pyridines was evaluated in the context of developing improved imaging agents for β-amyloid (Aβ) in Alzheimer’s disease (AD) and as a useful probe for in vitro studies. The results from binding experiments in vitro, together with biodistribution studies, autoradiography and in vivo stability studies demonstrated that radioiodinated 2-(4′-bromophenyl)-6-iodoimidazo[1,2-a]pyridine (BrIMPY, 4b) is promising for preclinical and clinical imaging of Aβ. The no-carrier-added radioiodination of 4b was successfully performed through an iododestannylation reaction from the corresponding trimethyltin derivative. [125I]4b and [124I]4b selectively labeled Aβ-plaques in brain tissue of an APP/PS1 mouse model of AD and their pattern of uptake showed excellent correlation with Aβ plaque pathology as measured by ex vivo immunohistochemistry. The present results suggest that radioiodinated 4b possesses the properties needed as a tracer suitable for in vivo and in vitro studies, with potential for both PET and SPECT imaging of β-amyloid plaques in the living brain.

In Vitro Study

Study Snapshot

Radioiodinated 2-(4′-bromophenyl)-6-iodoimidazo[1,2-a]pyridine (BrIMPY, 4b) shows promising potential for non-invasive imaging of Alzheimer's disease -amyloid plaques in living brain tissue.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Development of an improved radioiodinated 2-phenylimidazo[1,2-a]pyridine for non-invasive imaging of amyloid plaques

Sign up to use Study Snapshot

References

Small-Animal PET Imaging of Amyloid-Beta Plaques with [11C]PiB and Its Multi-Modal Validation in an APP/PS1 Mouse Model of Alzheimer's Disease

This study successfully developed a feasible, reproducible, and robust protocol for non-invasive amyloid- PET imaging in APP/PS1 mice, providing a foundation for translational Alzheimer neuroimaging in transgenic mice.

A Novel (18)F-Labeled Imidazo[2,1-b]benzothiazole (IBT) for High-Contrast PET Imaging of β-Amyloid Plaques.

[(18)F]8 is a promising high-contrast PET imaging agent for detecting -amyloid plaques in Alzheimer's disease mouse models, with potential for clinical evaluation.

Synthesis and evaluation of 11C-labeled imidazo[2,1-b]benzothiazoles (IBTs) as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.

IBTs show potential as high-sensitivity PET imaging agents for detecting Alzheimer's disease -amyloid plaques in the brain.

Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease

ARTE10 mice show early onset and robust cerebral -amyloidosis, making them suitable for target validation and evaluating diagnostic or therapeutic agents targeting Alzheimer's disease amyloid pathology.

Development of positron-emission tomography/single-photon emission computed tomography imaging probes for in vivo detection of beta-amyloid plaques in Alzheimer's brains.

PET/SPECT imaging agents for in vivo detection of beta-amyloid plaques in Alzheimer's brains could serve as surrogate markers for early diagnosis and neuropathogenetic studies.

Citations

Mapping the Binding Interface of PET Tracer Molecules and Alzheimer Disease Aβ Fibrils by Using MAS Solid‐State NMR Spectroscopy

PET tracer molecules interact with Alzheimer's disease A fibrils, stabilizing their structure and suppressing fibril polymorphism.

Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases.

Imidazopyridine-based compounds show potential as powerful modulators of central nervous system dysfunction, potentially benefiting diseases like Alzheimer's, Parkinson's, schizophrenia, depression, and sleeping disorders.

An Efficient Synthesis of Imidazo[1,2-a]pyridines

CsF-Celite post-treatment enhances the yield and simplifies the synthesis of imidazo[1,2-a]pyridines, making it a more efficient and cost-effective method.

Efficient and green microwave-assisted one-pot synthesis of azaindolizines in PEG-400 and water

Microwave-assisted one-pot synthesis of imidazo[1,2-a]pyridines in PEG-400 and water is a convenient, environmentally benign, and efficient method for producing azaindolizines without using toxic organic solvents.

FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice

[18F]FIBT shows promising imaging properties for Alzheimer's disease pathology, with high initial brain uptake, fast clearance, and high binding affinity towards A compared to established amyloid tracers.